Scientists Grab $11 Million to Study AstraZeneca PLC (AZN)'s Failed Drugs  
10/31/2012 6:15:26 AM

British academic researchers have secured 7 million pounds ($11 million) of funding from the country's Medical Research Council (MRC) to investigate a range of potential new drugs made available free-of-charge by AstraZeneca.

The move is the latest example of how the pharmaceutical industry is experimenting with new research models involving greater collaboration with external partners.